{"errors":{},"id":3755124,"source_code":"DMDRN","source_name":"Damodaran Financial Data","code":"DRTX_ALLFINANCIALRATIOS","name":"Durata Therapeutics Inc. ( DRTX ) - All Financial Ratios","urlize_name":"Durata-Therapeutics-Inc-DRTX-All-Financial-Ratios","description":"Corporate Finance data is collected and calculated by Prof. Aswath\nDamodaran, Professor of Finance at the Stern School of Business, New\nYork University.  The raw data is available here:\nhttp://pages.stern.nyu.edu/~adamodar/New_Home_Page/data.html","updated_at":"2014-03-22T12:44:21Z","frequency":"annual","from_date":"2011-12-31","to_date":"2011-12-31","column_names":["Date","Number of Shares Outstanding","Capital Expenditures","Cash","Cash as Percentage of Firm Value","Depreciation","Dividend Yield","Dividends","Effective Tax Rate","Enterprise Value","Firm Value","Hi-Lo Risk","Institutional Holdings","Market Capitalization","Market Debt to Equity Ratio","Market Debt to Capital Ratio","Net Income","Non-Cash Working Capital","Reinvestment Amount","Sales General and Administration Expenses","Stock Price","Total Debt","Trading Volume"],"private":false,"type":null,"display_url":"http://pages.stern.nyu.edu/~adamodar/New_Home_Page/data.html","data":[["2011-12-31",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,136.8,136.8,0.2282,0.173,136.8,0.0,0.0,0.0,0.0,0.0,0.0,7.64,0.0,11292.0]]}